Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B.

BMJ open - 29 Jul 2015

Wakata Kouki, Tsuchiya Tomoshi, Tomoshige Koichi, Takagi Katsunori, Yamasaki Naoya, Matsumoto Keitaro, Miyazaki Takuro, Nanashima Atsushi, Whitsett Jeffrey A, Maeda Yutaka, Nagayasu Takeshi

Abstract excerpt

OBJECTIVES: To determine the use of the mucin proteins MUC5B and MUC5AC as prognosis markers for non-small cell lung cancer (NSCLC) carrying epidermal growth factor receptor (EGFR) mutations. SETTING: Patients who underwent surgical resection at Nagasaki University Hospital and related facilities...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mucin 5AC

Share to Mucin-5B

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 26224019
DOI: 10.1136/bmjopen-2015-008366
PMCID: PMC4521511

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26224019-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B.PMID 26224019Read ↗

Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and its Role in Evaluation of PrognosisSemantic proximity Read ↗

Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.Semantic proximity Read ↗

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer.Semantic proximity Read ↗

MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer.Semantic proximity Read ↗

Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation.Semantic proximity Read ↗

Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.Semantic proximity Read ↗

Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.Semantic proximity Read ↗

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.